← Leaderboards
Ramin Samadani
University Of Maryland Baltimore
$81,099
Attributed
$81,099
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $27.3K · FY2012–14$50K$37.5K$25K$12.5K$0
'12
'13
'14
Funding mix
By agency
NIH$81,099 · 1
By mechanism
F31$81,099 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Peter B Crino$17,911,903
- Susan G Dorsey$16,761,780
- David Joseph Weber$22,294,951
- Feyruz Virgilia Rassool$1,878,287
- France Carrier$2,949,818
Others in their field
Top investigators on “Kinase Inhibitor”
- David Heimbrook · Leidos Biomedical Research, Inc.$48,781,331
- Peter Karl Sorger · Massachusetts Institute Of Technology$25,788,161
- Gary L. Johnson · National Jewish Health$20,941,451
- Lewis C Cantley · Beth Israel Deaconess Medical Center$20,644,037
- Pasi A Janne · Stanford University$20,635,755
- Robert C Bast · University Of Texas Md Anderson Can Ctr$20,614,985
Research focus
Kinase InhibitorAffectAmerican Cancer SocietyBaseBraf GeneAreaArginineCell ProliferationCellsCell SurvivalClinically RelevantClinical TrialsCombined Modality TherapyBypassDrug ResistanceCell LineEfficacy TestingEventFutureHuman Map3k8 ProteinIncidenceInduced MutationInhibitor/AntagonistLife
Grant awards (3)
Overcoming Drug-Induced Resistance in BRaf mutated melanoma cells$27,329
F31 · FY2014 · GM · contact PI
Overcoming Drug-Induced Resistance in BRaf mutated melanoma cells$26,885
F31 · FY2013 · GM · contact PI
Overcoming Drug-Induced Resistance in BRaf mutated melanoma cells$26,885
F31 · FY2012 · GM · contact PI